| Comparison of information-dependent acquisition on a tandem quadrupole TOF vs a triple quadrupole linear ion trap mass spectrometer for broad-spectrum drug screening KL Thoren, JM Colby, SB Shugarts, AHB Wu, KL Lynch Clinical Chemistry 62 (1), 170-178, 2016 | 77 | 2016 |
| Comparison of umbilical cord tissue and meconium for the confirmation of in utero drug exposure JM Colby Clinical biochemistry 50 (13-14), 784-790, 2017 | 58 | 2017 |
| Cross-reactivity of acetylfentanyl and risperidone with a fentanyl immunoassay BT Wang, JM Colby, AHB Wu, KL Lynch Journal of Analytical Toxicology 38 (9), 672-675, 2014 | 54 | 2014 |
| Detection of drug-exposed newborns SL Wabuyele, JM Colby, GA McMillin Therapeutic Drug Monitoring 40 (2), 166-185, 2018 | 50 | 2018 |
| Dynamic localization of G proteins in Dictyostelium discoideum CA Elzie, J Colby, MA Sammons, C Janetopoulos Journal of cell science 122 (15), 2597-2603, 2009 | 46 | 2009 |
| Cardiogenic shock after use of fluoroamphetamine confirmed with serum and urine levels S Al-Abri, KH Meier, JM Colby, CG Smollin, NL Benowitz Clinical Toxicology 52 (10), 1292-1295, 2014 | 36 | 2014 |
| Suspect screening using LC–QqTOF is a useful tool for detecting drugs in biological samples JM Colby, KL Thoren, KL Lynch Journal of analytical toxicology 42 (4), 207-213, 2018 | 34 | 2018 |
| Evaluation of procalcitonin immunoassay concordance near clinical decision points AB Chambliss, J Hayden, JM Colby Clinical Chemistry and Laboratory Medicine (CCLM) 57 (9), 1414-1421, 2019 | 30 | 2019 |
| High-resolution mass spectrometry for untargeted drug screening AHB Wu, J Colby Clinical applications of mass spectrometry in drug analysis: methods and …, 2016 | 29 | 2016 |
| Therapeutic drug monitoring of piperacillin and tazobactam by RP-HPLC of residual blood specimens SM Verhoven, JJ Groszek, WH Fissell, A Seegmiller, J Colby, P Patel, ... Clinica chimica acta 482, 60-64, 2018 | 27 | 2018 |
| Optimization and validation of high-resolution mass spectrometry data analysis parameters JM Colby, KL Thoren, KL Lynch Journal of Analytical Toxicology 41 (1), 01-05, 2017 | 25 | 2017 |
| Discovering cross-reactivity in urine drug screening immunoassays through large-scale analysis of electronic health records JJ Hughey, JM Colby Clinical Chemistry 65 (12), 1522-1531, 2019 | 24 | 2019 |
| Umbilical cord tissue and meconium may not be equivalent for confirming in utero substance exposure JM Colby, BC Adams, A Morad, LD Presley, SW Patrick The Journal of pediatrics 205, 277-280, 2019 | 24 | 2019 |
| Rapid assessment of drugs of abuse JR Wiencek, JM Colby, JH Nichols Advances in Clinical Chemistry 80, 193-225, 2017 | 24 | 2017 |
| Mass spectrometry in emergency toxicology: Current state and future applications XMR Van Wijk, R Goodnough, JM Colby Critical reviews in clinical laboratory sciences 56 (4), 225-238, 2019 | 23 | 2019 |
| Massive naproxen overdose with serial serum levels SA Al-Abri, IB Anderson, F Pedram, JM Colby, KR Olson Journal of Medical Toxicology 11, 102-105, 2015 | 20 | 2015 |
| Voxelotor (GBT440) produces interference in measurements of hemoglobin S NJ Rutherford, KL Thoren, Z Shajani-Yi, JM Colby Clinica chimica acta; international journal of clinical chemistry 482, 57, 2018 | 18 | 2018 |
| Voxelotor treatment interferes with quantitative and qualitative hemoglobin variant analysis in multiple sickle cell disease genotypes NJ Rutherford-Parker, ST Campbell, JM Colby, Z Shajani-Yi American journal of clinical pathology 154 (5), 627-634, 2020 | 16 | 2020 |
| Commonly used fluoroquinolones cross-react with urine drug screens for opiates, buprenorphine, and amphetamines JM Colby, PC Patel, DY Fu, NJ Rutherford Clinical Biochemistry 68, 50-54, 2019 | 15 | 2019 |
| Targeted strategy to analyze antiepileptic drugs in human serum by lc-ms/ms and lc-ion mobility-ms DE Davis Jr, SD Sherrod, RL Gant-Branum, JM Colby, JA McLean Analytical chemistry 92 (21), 14648-14656, 2020 | 11 | 2020 |
